BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals’ Management Team will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.
The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: www.progen-pharma.com
If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.
About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.
CONTACT: Progen Information: Linton Burns, Progen Pharmaceuticals Limited,
+61-7-3842-3333, lintonb@progen-pharma.com; Media and Investor Relations
Australia: Cindy Ingram, Progen Pharmaceuticals Limited, +61-7-3842-3333,
cindyi@progen-pharma.com; Media Relations USA: Robert D. Stanislaro,
Financial Dynamics, +1-212-850-5657; Investor Relations USA: Evan Smith,
Financial Dynamics, +1-212-850-5606, evan.smith@fd.com
Web site: http://www.progen-pharma.com//
